日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antiretroviral therapy initiated during acute infection in women with HIV-1 clade C reduces anti-Tat antibody production and lowers CD8+ T cell activation

在HIV-1 C亚型感染女性急性期开始的抗逆转录病毒疗法可降低抗Tat抗体的产生并降低CD8+ T细胞的活化。

Kubheka, Thandeka I; Naidoo, Kewreshini; Reddy, Kavidha; Ndung'u, Thumbi; Mkhwanazi, Nompumelelo P

Altered mitochondrial mass and fatty acid uptake by natural killer cells in HIV-exposed uninfected children at 6 years of age

6岁时,暴露于HIV但未感染的儿童体内线粒体质量和自然杀伤细胞对脂肪酸的摄取发生改变

Mataramvura, Hope; Jordan-Paiz, Ana; Naidoo, Kewreshini; Jaeger, Julia; Testa, Lucia; Gumbo, Felicity Z; Mazengera, Ronald L; Bunders, Madeleine J; Duri, Kerina

Early Initiation of Antiretroviral Therapy Preserves the Metabolic Function of CD4+ T Cells in Subtype C Human Immunodeficiency Virus 1 Infection

早期启动抗逆转录病毒疗法可保护C亚型人类免疫缺陷病毒1型感染中CD4+ T细胞的代谢功能

Naidoo, Kewreshini K; Highton, Andrew J; Baiyegunhi, Omolara O; Bhengu, Sindiswa P; Dong, Krista L; Bunders, Madeleine J; Altfeld, Marcus; Ndung'u, Thumbi

Early antiretroviral therapy and its impact on natural killer cell dynamics in HIV-1 infected men who have sex with men: a cross-sectional pilot study evaluating the impact of early ART initiation on NK cell perturbation in HIV infection

早期抗逆转录病毒疗法及其对男男性行为者HIV-1感染者自然杀伤细胞动态的影响:一项评估早期启动抗逆转录病毒疗法对HIV感染中NK细胞扰动影响的横断面试点研究

Akiso, Matrona; Muema, Daniel; Langat, Robert; Naidoo, Kewreshini K; Oino, Geoffrey; Mutua, Gaudensia; Thobakgale, Christina; Ochiel, Daniel; Chinyenze, Kundai; Anzala, Omu; Mureithi, Marianne W

The Role of Natural Killer Cells and Their Metabolism in HIV-1 Infection

自然杀伤细胞及其代谢在HIV-1感染中的作用

Naidoo, Kewreshini K; Altfeld, Marcus

Metabolic and mitochondrial dysregulation in CD4+ T cells from HIV-positive women on combination anti-retroviral therapy

接受联合抗逆转录病毒治疗的 HIV 阳性女性 CD4+ T 细胞代谢和线粒体失调

Matrona Akiso, Magdalene Ameka, Kewreshini Naidoo, Robert Langat, Janet Kombo, Delories Sikuku, Thumbi Ndung'u, Marcus Altfeld, Omu Anzala, Marianne Mureithi

Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles

具有和不具有保护性HLA等位基因的初治HIV-1病毒血症控制者,其自然杀伤细胞、T细胞和抗体谱存在差异

Moyano, Ana; Ndlovu, Bongiwe; Mbele, Msizi; Naidoo, Kewreshini; Khan, Nasreen; Mann, Jaclyn K; Ndung'u, Thumbi

Bone marrow stromal antigen 2 (BST-2) genetic variants influence expression levels and disease outcome in HIV-1 chronically infected patients

骨髓基质抗原 2 (BST-2) 基因变异影响 HIV-1 慢性感染患者的表达水平和疾病结果

Hlelolwenkosi Mlimi, Kewreshini K Naidoo, Jenniffer Mabuka, Thumbi Ndung'u, Paradise Madlala

Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection

尽管在超急性 HIV-1 感染期间开始抗逆转录病毒治疗,抗原呈递细胞仍有助于持续免疫激活

Kewreshini K Naidoo, Okechukwu C Ndumnego, Nasreen Ismail, Krista L Dong, Thumbi Ndung'u

HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype

HIV-1 可逃避 Gag 突变,该突变会破坏杀伤细胞免疫球蛋白样受体的结合,并解除携带 KIR2DL2+/HLA-C*03:04+ 基因型感染者体内自然杀伤细胞的抑制。

Ziegler, Maja C; Naidoo, Kewreshini; Chapel, Anais; Nkotwana, Sindiswa; Mann, Jaclyn; Mncube, Zenele; Ismael, Nasreen; Goulder, Philip; Ndung'u, Thumbi; Altfeld, Marcus; Thobakgale, Christina F